Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Achondrogenesis Type 1B

Sheila Unger  1 , Andrea Superti-Furga  2
Margaret P Adam, Sarah Bick, Ghayda M Mirzaa, Roberta A Pagon, Stephanie E Wallace, Anne Amemiya
, editors.
In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993.
[updated ].
Affiliations
Free Books & Documents
Review

Achondrogenesis Type 1B

Sheila Unger et al.
Free Books & Documents

Excerpt

Clinical characteristics: Clinical features of achondrogenesis type 1B (ACG1B) include extremely short limbs with short fingers and toes, hypoplasia of the thorax, protuberant abdomen, and hydropic fetal appearance caused by the abundance of soft tissue relative to the short skeleton. The face is flat, the neck is short, and the soft tissue of the neck may be thickened. Death occurs prenatally or shortly after birth.

Diagnosis/testing: The diagnosis of ACG1B is established in a proband with characteristic clinical, radiologic, and histopathologic features. Identification of biallelic pathogenic variants in SLC26A2 on molecular genetic testing can confirm the diagnosis.

Management: Treatment of manifestations: Palliative care for live-born neonates.

Genetic counseling: ACG1B is inherited in an autosomal recessive manner. If both parents are known to be heterozygous for an SLC26A2 pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of inheriting neither of the familial SLC26A2 pathogenic variants. Once the SLC26A2 pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives, prenatal testing for a pregnancy at increased risk, and preimplantation genetic testing are possible.

PubMed Disclaimer

References

    1. Barbosa M, Sousa AB, Medeira A, Lourenço T, Saraiva J, Pinto-Basto J, Soares G, Fortuna AM, Superti-Furga A, Mittaz L, Reis-Lima M, Bonafé L. Clinical and molecular characterization of Diastrophic Dysplasia in the Portuguese population. Clin Genet. 2011;80:550-7. - PubMed
    1. Bonafé L, Hästbacka J, de la Chapelle A, Campos-Xavier AB, Chiesa C, Forlino A, Superti-Furga A, Rossi A (2008) A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. J Med Genet 45:827-31 - PMC - PubMed
    1. Cai G, Nakayama M, Hiraki Y, Ozono K (1998) Mutational analysis of the DTDST gene in a fetus with achondrogenesis type 1B. Am J Med Genet 78:58-60 - PubMed
    1. Corsi A, Riminucci M, Fisher LW, Bianco P (2001) Achondrogenesis type IB: agenesis of cartilage interterritorial matrix as the link between gene defect and pathological skeletal phenotype. Arch Pathol Lab Med 125:1375-8 - PubMed
    1. Dwyer E, Hyland J, Modaff P, Pauli RM (2010) Genotype-phenotype correlation in DTDST dysplasias: atelosteogenesis type II and diastrophic dysplasia variant in one family. Am J Med Genet A. 152A:3043-50. - PubMed

LinkOut - more resources